Protein Engineering

  • Sudhir Paul
Part of the Springer Protocols Handbooks book series (SPH)


The three-dimensional arrangement of ammo acids in a protein dictates its biological properties One of the urgent challenges of modern biology is to decipher the relationship between the linear sequence of ammo acids and the conformation adopted by proteins Success is predicting protein conformation from the primary structure can be anticipated to permit rational design of therapeutic formulations to treat intractable human diseases and of probes for research in fundamental biological problems


Malate Dehydrogenase Linker Sequence Active Site Structure Domain Expansion Antibody Construct 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    DeGrado, W F, Wasserman, Z R, and Lear, J D (1989) Protem design, a minimalist approach Science 243, 622–628PubMedGoogle Scholar
  2. 2.
    Sander, C (1994) Structural design of proteins, in Concepts in Protein Engineering and Design An Introduction (Wrede, P and Schneider, G, eds), Walter de Gruyter, New York,pp 209–236Google Scholar
  3. 3.
    Engel, M, William, S R, and Erickson, B (1991) Designed coiled-coil proteins synthesis and spectroscopy of two 78-residue a-hehcal dimers Biochemistry 30, 3161–3169PubMedGoogle Scholar
  4. 4.
    Regan, L and DeGrado, W F(1988) Characterization of a helical protein designed from first principles Science 241, 976–978PubMedGoogle Scholar
  5. 5.
    Davies, D R, Padlan, E A, and Sheriff, S (1990) Antibody-antigen complexes Ann Rev Biochem 59, 439–474PubMedGoogle Scholar
  6. 6.
    Novotny, J, Bruccolen, R E, and Saul, F A (1989) On the attribution of binding energy in antigen-antibody complexes McPc 603, Dl 3 and HyHel-5 Biochemistry 28, 4735–4749PubMedGoogle Scholar
  7. 7.
    Wdthrich, K (1989) Protein structure determination in solution by nuclear magnetic resonance spectroscopy Science 243, 45–50Google Scholar
  8. 8.
    Hirs, C H W and Timasheff, S N (eds) (1986) Methods in Enzymology, Vol 130, Enzyme Structure, Part K Academic, New YorkGoogle Scholar
  9. 9.
    Webster, D M and Rees, A R (1995) Molecular modeling of antibody-combining sites, in Methods in Molecular Biology, vol 51 Antibody Engineering Protocols (Paul, S, ed), Humana, Totowa, NJ, pp 17–49Google Scholar
  10. 10.
    Lundbland, R and Noyes, C M (1984) Chemical Reagents for Protein Modification, Vols I and II CRC, Boca Raton, FLGoogle Scholar
  11. 11.
    Wong, S S (1991) Chemistry of Protein Conjugation and Cross-Linking CRC, Boca Raton, FLGoogle Scholar
  12. 12.
    Weir, M, Herzenberg, L A, Blackwell, C, and Herzenberg, L A (eds) (1986) Handbook of Experimental Immunology Blackwell, Oxford, UKGoogle Scholar
  13. 13.
    Kohler, G and Milstein, C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256, 495–497PubMedGoogle Scholar
  14. 14.
    Marks, J D, Hoogenboom, H R, Borniert, T P, McCafferty, J, Griffiths, A D, and Winter, G (1991) By-passing immunization Human antibodies from V-gene libraries displayed on phage J Mol Biol 222, 581–597PubMedGoogle Scholar
  15. 15.
    Clackson, T, Hoogenboom, H R, Griffiths, A D, and Winter, G (1991) Making antibody fragments using phage display libraries Nature 352, 624–628PubMedGoogle Scholar
  16. 16.
    Jerne, N K, Roland, J, and Cazenave, P A (1982) Recurrent idiotypes and internal images EMBO J 1, 243–247PubMedGoogle Scholar
  17. 17.
    Glasel, J A and Agarwal, D (1995) Anti-idiotypic antibodies that mimic opioids, in Methods in Molecular Biology, vol 51 Antibody Engineering Protocols (Paul, S, ed), Humana, Totowa, NJ, pp 183–201Google Scholar
  18. 18.
    Somjen, D, Amir-Zaltsman, Y, Gayer, B, Mor, G, Jaccard, N, Weisman, Y, Barnard, G, and Kohen, F (1995) Anti-idiotypic antibody as an oestrogen mimetic removal of Fc fragment converts agonist to antagonist J Endocrinol 145, 409–416PubMedGoogle Scholar
  19. 19.
    Izadyar, L, Friboulet, A, Remy, M H, Roseto, A, and Thomas, D (1993) Monoclonal anti-idiotypic antibodies as functional internal images of enzymes active sites production of a catalytic antibody with a chohnesterase activity Proc Nat I Acad Sci USA 90, 8876–8880Google Scholar
  20. 20.
    Costagliola, S, Ruf, J, Durand-Gorde, M J, and Carayon, P (1991) Monoclonal antiidiotypic antibodies interact with the 93 kilodalton thyrotropin receptor and exhibit heterogeneous biological activities Endocrinology 128, 1555–1562PubMedGoogle Scholar
  21. 21.
    Tramontano, A, Janda, K D, and Lerner, R A (1986) Catalytic antibodies Science 234, 1566–1570PubMedGoogle Scholar
  22. 22.
    Pollack, S J, Jacobs, J. W, and Schultz, P G. (1986) Selective chemical catalysis by an antibody Science 234, 1570–1573PubMedGoogle Scholar
  23. 23.
    Stewart, J D and Benkovic, S J (1995) Transition-state stabilization as a measure of the efficiency of antibody catalysis Nature 375, 388–391PubMedGoogle Scholar
  24. 24.
    Kraut, J (1988) How do enzymes work? Science 242, 533–540PubMedGoogle Scholar
  25. 25.
    Paul, S, Volle, D J, Beach, C M, Johnson, D R, Powell, M J, and Massey, R J (1989) Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody Science 244, 1158–1162PubMedGoogle Scholar
  26. 26.
    Shuster, A M, Gololobov, G V, Kvashuk, O A, Bogomolova, A E, Smirnov, I V, and Gabibov, A G (1992) DNA hydrolyzing autoantibodies Science 256, 665–667PubMedGoogle Scholar
  27. 27.
    Li, L, Paul, S, Tyutyulkova, S, Kazatchkine, M, and Kaven, S (1995) Catalytic activity of anti-thyroglobulin antibodies J Immunol 154, 3328–3332PubMedGoogle Scholar
  28. 28.
    Kalaga, R, Li, L, O’Dell, J, and Paul, S (1995) Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis J Immunol 155, 2695–2702PubMedGoogle Scholar
  29. 29.
    Sun, M, Mody, B, Eklund, S H, and Paul, S (1991) Vasoactive intestinal peptide hydrolysis by antibody light chains J Biol Chem 266, 15,571–15,574Google Scholar
  30. 30.
    Gao, Q S, Sun, M, Tyutyulkova, S, Webster, D, Rees, A, Tramontano, A, Massey, R, and Paul, S (1994) Molecular cloning of a proteolytic antibody light chain J Biol Chem 269, 32,389–32,393PubMedGoogle Scholar
  31. 31.
    Takagi, M, Kohda, K, Hamuro, T, Harada, A, Yamaguchi, H, Kamachi, M, and Imanaka, T (1995) Thermostable peroxidase activity with a recombinant antibody L chain-porphyrin Fe(III) complex FEBS Lett 375, 273–276PubMedGoogle Scholar
  32. 32.
    Gao, Q S, Sun, M, Rees, A, and Paul, S (1995) Site-directed mutagenesis of proteolytic antibody light chain J Mol Biol 253, 658–664PubMedGoogle Scholar
  33. 33.
    Khalaf, A I, Proctor, G R, Suckling, C J, Bence, L H, Irvine, J I, and Stimson, W H (1992) Remarkably efficient hydrolysis of a 4-nitrophenylester by a catalytic antibody raised to an ammonium hapten J Chem Soc (Perkin 1) 1, 1475–1481Google Scholar
  34. 34.
    Marks, J D, Tristem, M, Karpas, A, and Winter, G (1991) Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific ohgonucleotide probes Eur J Immunol 21, 985–991PubMedGoogle Scholar
  35. 35.
    Deng, S, MacKenzie, C R, and Narang, S A (1995) Synthetic antibody gene libraries for in vitro affinity maturation, in Methods in Molecular Biology, vol 51 Antibody Engineering Protocols (Paul, S, ed), Humana, Totowa, NJ, pp 329–342Google Scholar
  36. 36.
    Glockshuber, R, Schmidt, T, and Pluckthun, A (1992) The disulfide bonds in antibody variable domains effects on stability, folding in vitro, and functional expression in Eschenchia coli Biochemistry 31, 1270–1279Google Scholar
  37. 37.
    Sun, M, Gao, Q S, Li, L, and Paul, S (1994) Proteolytic activity of an antibody light chain J Immunol 153, 5121–5126PubMedGoogle Scholar
  38. 38.
    Flecker, P (1995) Template-directed protein folding into a metastable state of increased activity Eur J Biochem 232, 528–535PubMedGoogle Scholar
  39. 39.
    Braco, L, Dabulis, K, and Klibanov, A M (1990) Production of abiotic receptors by molecular imprinting of proteins Proc Natl Acad Sci USA 87, 274–277PubMedGoogle Scholar
  40. 40.
    Chen, S T, Chen, S Y, and Wang, K T (1992) Kinetically controlled peptide bond formation in anhydrous alcohol catalyzed by the industrial protease alcalase J Org Chem 57, 6960–6965Google Scholar
  41. 41.
    Deschrevel, B, Vincent, J C, and Thellier, M (1993) Kinetic study of the α-chymotrypsin-catalyzed hydrolysis and synthesis of a peptide bond in a monophasic aqueous/ organic reaction medium Arch Biochem Biophys 304, 45–52PubMedGoogle Scholar
  42. 42.
    Matsumura, M and Matthews, B W (1991) Stabilization of functional proteins by introduction of multiple disulfide bonds, in Methods in Enzymology, Vol 202 (Langone, J J, ed), Academic, New York, pp 336–356Google Scholar
  43. 43.
    Arnold, F H (1993) Engineering proteins for nonnatural environments FASEB J 7, 744–749PubMedGoogle Scholar
  44. 44.
    Menèndez-Arias, L and Argos, P (1989) Engineering protein thermal stability Sequence statistics point to residue substitutions in cY-helices J Mol Biol 206, 397–406PubMedGoogle Scholar
  45. 45.
    Novotny, J, Ganju, R K, Smiley, S T, Hussey, R E, Luther, M A, Recny, M A, Siliciano, R F, and Reinhjerz, E L (1991) A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties Proc Natl Acad Sci USA 88, 8646–8650PubMedGoogle Scholar
  46. 46.
    Bianchi, E, Venturini, S, Pessi, A, Tramontano, A, and Sollazzo, M (1994) High level expression and rational mutagenesis of a designed protein, the minibody From an insoluble to a soluble molecule J Mol Biol 236, 649–659PubMedGoogle Scholar
  47. 47.
    Reichmann, L, Weill, M, and Cavanagh, J (1992) Improving the antigen affinity of an antibody Fv-fragment by protein design J Mol Biol 224, 913–918Google Scholar
  48. 48.
    Xiang, J, Chen, Z, Delbaere, L T J., and Liu, E (1993) Differences in antigen-binding affinity caused by a single ammo acid substitution m the variable region of the heavy chain Immunol Cell Biol 71, 239–247PubMedGoogle Scholar
  49. 49.
    Baldwin, E and Schultz, P G (1989) Generation of a catalytic antibody by site-directed mutagenesis Science 245, 1104–1107PubMedGoogle Scholar
  50. 50.
    Pollack, S J, Nakayama, G R, and Schultz, P G (1988) Introduction of nucleophiles and spectropscopic probes into antibody combining sites Science 242, 1038–1040PubMedGoogle Scholar
  51. 51.
    Kuroki, R, Weaver, L H, and Matthews, B W (1993) A covalent enzyme-substrate intermediate with saccharide distortion in a mutant T4 lysozyme Science 262, 2030–2034PubMedGoogle Scholar
  52. 52.
    Madison, E L, Kobe, A, Gething, M J, Sambrook, J F, and Goldsmith, E J (1993) Converting tissue plasminogen activator to a zymogen a regulatory triad of Asp-His-Ser Science 262, 419–424PubMedGoogle Scholar
  53. 53.
    Graf, L, Craik, C S, Patthy, A, Roczniak, S, Fletterick, R J, and Rutter, W J (1987) Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin Biochemistry 26, 2616–2623PubMedGoogle Scholar
  54. 54.
    Beaumont, A, Barbe, B, Le Moual, H, Boileau, G, Crine, P, Fournié-Zaluski, M C, and Rogues, B P (1992) Charge polarity reversal inverses the specificity of neutral endopeptidase-24 11 J Biol Chem 267, 2138–2141PubMedGoogle Scholar
  55. 55.
    Estell, D A, Graycar, T P, Miller, J V, Powers, D B, Burnier, J P, Ng, P G, and Wells, J A (1986) Probing steric and hydrophobic effects on enzyme-substrate interactions by protein engineering Science 233, 659–663PubMedGoogle Scholar
  56. 56.
    Paul, S, Volle, D J, Powell, M J, and Massey, R J (1990) Site specificity of a catalytic vasoactive intestinal peptide antibody An inhibitory vasoactive intestinal peptide subsequence distant from the scissile peptide bond J Biol Chem 265, 11,910–11,913PubMedGoogle Scholar
  57. 57.
    Wilks, H M, Hart, K W, Feeney, R, Dunn, C R, Muirhead, H, Chia, W C, Barsow, D A, Atkinson, T, Clarke, A R, and Holbrook J J (1988) A specific, highly active malate dehydrogenase by redesign of a lactate dehydrogenase framework Science 242, 1541–1544PubMedGoogle Scholar
  58. 58.
    Scrutton, N S, Berry, A, and Perham, R N (1990) Redesign of the coenzyme specificity of a dehydrogenase by protein engineering Nature (London) 343, 38–43Google Scholar
  59. 59.
    Alvaro, G and Russell, A J (1991) Modification of enzyme catalysis by engineering surface charge, in Methods in Enzymology, Vol 202 (Langone, J J, ed), New York, Academic, pp 620–643Google Scholar
  60. 60.
    Muraki, M, Monkawa, M, Jigami, Y, and Tanaka, H (1988) Engineering of human lysozyme as a polyelectrolyte by the alteration of molecular surface charge Protein Eng 21, 49–54Google Scholar
  61. 61.
    Gilbert, W (1978) Why genes in pieces? Nature (London) 271, 501Google Scholar
  62. 62.
    Sun, M, Li, L, Gao, Q S, and Paul, S (1994) Antigen recognition by an antibody light chain J Biol Chem 269, 734–738PubMedGoogle Scholar
  63. 63.
    Ward, E. S, Gussow, D, Griffiths, A D, Jones, P T, and Winter, G (1989) Binding activities of a repertoire of single immunoglobulin variable domains secreted for Escherichia coli Nature 341, 544–546PubMedGoogle Scholar
  64. 64.
    Kang, C. Y, Brunck, T K, Kieber-Emmons, T, Blalock, J E, and Kohler, H (1988) Inhibition of self-binding antibodies (autoantibodies) by a VH-denved peptide Science 240, 1034–1036PubMedGoogle Scholar
  65. 65.
    Igarashi, K., Asai, K, Kaneda, M., Umeda, M, and Inoue, K (1995) Specific binding of a synthetic peptide derived from an antibody complementanly determining region to phosphatidylsenne J Biochem (Tokyo) 117, 452–457Google Scholar
  66. 66.
    Clackson, T and Wells, J A (1995) A hot spot of binding energy in a hormone-receptor interface Science 267, 383–386PubMedGoogle Scholar
  67. 67.
    Mody, R K, Tramontano, A, and Paul, S (1994) Spontaneous hydrolysis of vasoactive intestinal peptide in neutral aqueous solution Int J Pept Protein Res 44, 441–447PubMedGoogle Scholar
  68. 68.
    Hahn, K W, Khs, W A, and Stewart, J M (1990) Design and synthesis of a peptide having chymotrypsin-hke esterase activity Science 248, 1544–1546PubMedGoogle Scholar
  69. 69.
    Paul, S, Li, L, Kalaga, R, Wilkins-Stevens, P, Stevens, F J, and Solomon, A (1995) Natural catalytic antibodies Peptide hydrolyzing activities of Bence Jones proteins and VL fragment J Biol Chem 270, 15,257–15,261PubMedGoogle Scholar
  70. 70.
    Hruby, V J and Nikiforovitch, G V (1991) The Ramachandran Plot and beyond conformational and topochemical considerations in the design of peptides and proteins, in Molecular Conformation and Biological Interactions (Balaram, P and Ramasehan, S, eds), Indian Academy of Sciences, Bangalore, India, pp 429–445Google Scholar
  71. 71.
    Marshall, G (1993) A hierarchical approach to peptidomimetic design Tetrahedron 49, 3547–3558Google Scholar
  72. 72.
    Musso, G F, Patthi, S, Ryskamp, T C, Provow, S, Kaiser, E T, and Velicelebi, G (1988) Development of helix-based vasoactive intestinal peptide analogues identification of residues required for receptor interaction Biochemistry 27, 8174–8181PubMedGoogle Scholar
  73. 73.
    Bird, R E, Hardman, K D, Jacobson, J W., Johnson, S, Kaufman, B M, Lee, S, Lee, T, Pope, S H, Riordan, G S, and Whitlow, M (1988) Single-chain antigen-binding proteins Science 142, 423–426Google Scholar
  74. 74.
    Whitlow, M, Bell, B A, Feng, S-L, Filpula, D, Hardman, K D, Hubert, S L, Rollence, M L, Wood, J F, Schott, M. E, Milenic, D E, Yokota, T, and Schlom, J (1993) An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability Protein Eng 6, 989–995PubMedGoogle Scholar
  75. 75.
    Bedzkyk, W D, Weidner, K M, Denzin, L K, Johnson, L S, Hardman, K D, Pantoliano, M W, Asel, E D, and Voss, E W, Jr (1990) Immunological and structural characterization of a high affinity anti-fluorescein single-chain antibody J Biol Chem 265, 18,615–18,620Google Scholar
  76. 76.
    Anand, N N, Mandai, S, MacKenzie, C R, Sadowska, J, Sigurskjold, B, Young, N M, Bundle, D R, and Narang, S A (1991) Bacterial expression and secretion of various single-chain Fv genes encoding proteins specific for a Salmonella serotype B O-antigen Bwl Chem 266, 21,874–21,879Google Scholar
  77. 77.
    Gao, Q S and Paul, S (1995) Molecular cloning of anti-ground state proteolytic antibody fragments, in Methods in Molecular Biology, Vol 51 Antibody Engineering Protocols (Paul, S, ed), Humana, Totowa, NJ, pp. 281–296Google Scholar
  78. 78.
    Chang, H C, Bao, Z Z, Yao, Y, Tse, A G D, Goyarts, E C, Madsen, M, Kawasaki, E, Brauer, P P, Sacchettini, J C, Nathenson, S G, and Reinherz, E L (1994) A general method for facilitating heterodimenc pairing between two proteins application to expression of a and β T-cell Proc Natl Acad Sci USA 91, 11,408–11,412PubMedGoogle Scholar
  79. 79.
    Corey, D R and Schultz, P G (1987) Generation of a hybrid sequence-specific single-stranded deoxynbonuclease Science 238, 1401–1406PubMedGoogle Scholar
  80. 80.
    Pendergrast, P S, Ebright, Y W, and Ebright, R H (1994) High-specificity DNA cleavage agent design and application to kilobase and megabase DNA substrates Science 265, 959–962PubMedGoogle Scholar
  81. 81.
    Pomerantz, J L, Sharp, P A, and Pabo, C O (1995) Structure-based design of transcription factors Science 267, 93–96PubMedGoogle Scholar
  82. 82.
    Lee, G, Chan, W, Hurle, M R, DesJarlais, R L, Watson, F, Sathe, G M, and Wetzel, R (1993) Strong inhibition of fibrinogen binding to platelet receptor αIIβ43 by RGD sequences installed into a presentation scaffold Protein Eng 6, 745–754PubMedGoogle Scholar
  83. 83.
    Bona, C, Brumeanu, T-D, and Zaghouani, H (1994) Immunogenicity of microbial peptides grafted in self immunoglobulin molecules Cell Mol Bwl 40(Suppl. I), 21–30Google Scholar
  84. 84.
    Ward, E S (1995) VH shuffling can be used to convert an Fv fragment of anti-hen egg lysozyme specificity to one that recognizes a T cell receptor Vα Mol Immunol 32, 147–156PubMedGoogle Scholar
  85. 85.
    Polymenis, M and Stollar, B D (1994) Critical binding site amino acids of anti-Z-DNA single chain Fv molecules role of heavy and light chain CDR3 and relationship to autoantibody activity J Immunol 152, 5318–5329PubMedGoogle Scholar
  86. 86.
    Gulliver, G A, Bedzyk, W D, Smith, R G, Bode, S L, Tetin, S Y, and Voss, E W, Jr (1994) Conversion of an anti-single-stranded DNA active site to an anti-fluorescein active site through heavy chain complementarily determining region transplantation J Biol Chem 269, 7934–7940PubMedGoogle Scholar
  87. 87.
    Gulliver, G A and Voss, E W., Jr (1994) Effect of transplantation of antibody heavy chain complementanly determining regions on ligand binding J Biol Chem 269, 24,040–24,045PubMedGoogle Scholar
  88. 88.
    Turner, S L, Russell, G C, Williamson, M P, and Guest, J R (1993) Restructuring an interdomain linker in the dihydrohpoamide acetyltransferase component of the pyruvate dehydrolgenase complex of Escherichia coli Protein Eng 6, 101–108PubMedGoogle Scholar
  89. 89.
    Holliger, P, Prospero, T, and Winter, G (1993) “Diabodies” small bivalent and bispecific antibody fragments Proc Natl Acad Sa USA 90, 6444–6448Google Scholar
  90. 90.
    Reiter, Y, Brinkmann, U, Webber, K O, Jung, S-H, Lee, B, and Pastan, I (1994) Engineering interchain disulfide bonds into conserved framework regions of Fv fragments Improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv Protein Eng 7, 697–704PubMedGoogle Scholar
  91. 91.
    Brinkmann, U, Reiter, Y, Jung, S-H, Lee, B, and Pastan, I (1993) A recombinant immunotoxin containing a disulfide-stabilized Fv fragment Proc Natl Acad Sci USA 90, 7538–7542PubMedGoogle Scholar
  92. 92.
    Pack, P, Muller, K, Zahn, R, and Pluckthun, A (1995) Tetravalent miniantibodies with high avidity assembling in Escherwhia coli J Mol Biol 246, 28–34PubMedGoogle Scholar
  93. 93.
    Neri, D, Momo, M, Prospero, T, and Winter, G (1995) High-affinity antigen binding by chelating recombinant antibodies (CRAbs) J Mol Biol 246, 367–373PubMedGoogle Scholar
  94. 94.
    Kurucz, I, Titus, J A, Jost, C R, Jacobus, C M, and Segal, D M (1995) Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria J Immunol 154, 4576–4582PubMedGoogle Scholar
  95. 95.
    Eshhar, Z, Waks, T, Gross, G, and Schindler, D G (1993) Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibodybinding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptois Proc Natl Acad Sa USA 90, 720–724Google Scholar
  96. 96.
    Gosink, M M and Vierstra, R D (1995) Redirecting the specificity of ubiquitmation by modifying ubiquitin-conjugating enzymes Proc Natl Acad Sci USA 92, 9117–9121PubMedGoogle Scholar
  97. 97.
    Chaudhary, V K, Batra, J K, Gallo, M. G, Willingham, M C, Fitzgerald, D J, and Pastan, I (1990) A rapid method of cloning functional variable-region antibody genes in Escherwhia cold as single-chain immunotoxins Proc Natl Acad Sci USA 87, 1066–1070PubMedGoogle Scholar
  98. 98.
    Kreitman, R J, Ballon, P, Chaudhary, V K, FitzGerald, D J P, and Pastan, I (1994) Recombmant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an mterleukin-2 receptor-expressing human carcinoma Blood 83, 426–434PubMedGoogle Scholar
  99. 99.
    Yang, J B, Moyana, T, and Xiang, J (1995) A genetically engineered single-chain FV/ TNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor Mol Immunol 32, 873–881PubMedGoogle Scholar
  100. 100.
    Pastan, I H, Archer, G E, McLendon, R E, Friedman, H S, Fuchs, H E, Wang, Q-C, Pai, L H, Herndon, J, and Bigner, D D (1995) Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model Proc Natl Acad Sei USA 92, 2765–2769Google Scholar
  101. 101.
    George, A J T, Jamar, F, Tai, M S, Heelan, B T, Adams, G P, McCartney, J E, Houston, L. L, Weiner, L M, Oppermann, H, Peters, A M, and Huston, J S (1995) Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site Technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide Proc Natl Acad Sei USA 92, 8358–8362Google Scholar
  102. 102.
    Holvoet, P, Laroche, Y, Lijnen, H R, Van Hoef, B, Brouwers, E, De Cock, F, Lauwereys, M, Gansemans, Y, and Collen, D (1992) Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase Eur J Biochem 210, 945–952PubMedGoogle Scholar
  103. 103.
    Bickel, U, Yoshikawa, T, Landaw, E M, Faull, K F, and Pardndge, W M (1993) Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery Proc Natl Acad Sci USA 90, 2618–2622PubMedGoogle Scholar
  104. 104.
    Rodrigues, M L, Presta, L G, Kotts, C E, Wirth, C, Mordenti, J, Osaka, G, Wong, W L T, Nuijens, A, Blackburn, B, and Carter, P (1995) Development of a humanized disulfide-stabihzed anti-pi 85HER2 Fv-β-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug Cancer Res 55, 63–70PubMedGoogle Scholar
  105. 105.
    Eisele, J L, Bertrand, S, Galzi, J L, Devillers-Thiéry, A, Changeux, J P, and Bertrand, D (1993) Chimaenc nicotinic-serotonergic receptor combines distinct ligand binding and channel specificitiess Nature 366, 479–483PubMedGoogle Scholar
  106. 106.
    Fuh, G, Cunningham, B C, Fukunaga, R, Nagata, S, Goeddel, D V, and Wells, J A (1992) Rational design of potent antagonists to the human growth hormone receptor Science 256, 1677–1684PubMedGoogle Scholar

Copyright information

© Humana Press Inc , Totowa, NJ. 1998

Authors and Affiliations

  • Sudhir Paul
    • 1
  1. 1.Department of AnestheszologyUnzverszty of Nebraska Medzcal CenterOmaha

Personalised recommendations